AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
RAS MUTATIONS IN PEDIATRIC LEUKEMIAS WITH MLL GENE REARRANGEMENTS
Authors: MAHGOUB N PARKER RI HOSLER MR CLOSE P WINICK NJ MASTERSON M SHANNON KM FELIX CA
Citation: N. Mahgoub et al., RAS MUTATIONS IN PEDIATRIC LEUKEMIAS WITH MLL GENE REARRANGEMENTS, Genes, chromosomes & cancer, 21(3), 1998, pp. 270-275
CITIZENSHIP, DEMOCRACY AND JUSTICE IN THE NEW EUROPE - LEHNING,PB, WEALE,A
Authors: CLOSE P
Citation: P. Close, CITIZENSHIP, DEMOCRACY AND JUSTICE IN THE NEW EUROPE - LEHNING,PB, WEALE,A, Journal of Common Market studies, 36(2), 1998, pp. 275-276
MITOTIC-ACTIVITY AND NUCLEAR-DNA DAMAGE OF LARGE CELLS IN HODGKINS-DISEASE - COMPARISON WITH THE EXPRESSION OF P53 AND BCL-2 PROTEINS AND THE PRESENCE OF EPSTEIN-BARR-VIRUS
Authors: LEONCINI L SPINA D CLOSE P MINACCI C MEGHA T DELUCA F TOSI P PILERI S KRAFT R LAISSUE JA COTTIER H
Citation: L. Leoncini et al., MITOTIC-ACTIVITY AND NUCLEAR-DNA DAMAGE OF LARGE CELLS IN HODGKINS-DISEASE - COMPARISON WITH THE EXPRESSION OF P53 AND BCL-2 PROTEINS AND THE PRESENCE OF EPSTEIN-BARR-VIRUS, Leukemia & lymphoma, 25(1-2), 1997, pp. 153-161
EFFECT OF AGE ON THE CHARACTERISTICS AND CLINICAL BEHAVIOR OF NON-HODGKINS-LYMPHOMA PATIENTS
Authors: CHAN WC ARMITAGE JO GASCOYNE R CONNORS J CLOSE P JACOBS P NORTON A LISTER TA PEDRINIS E CAVALLI F BERGER F COIFFIER B HO F LIANG R SCHAUER A HIDDEMANN W DIEBOLD J MACLENNAN KA MULLERHERMELINK HK NATHWANI BN WEISENBURGER DD ANDERSON JR ROY P
Citation: Wc. Chan et al., EFFECT OF AGE ON THE CHARACTERISTICS AND CLINICAL BEHAVIOR OF NON-HODGKINS-LYMPHOMA PATIENTS, Annals of oncology, 8(10), 1997, pp. 973-978
REGIONAL BLOCK ANESTHESIA VERSUS GENERAL-ANESTHESIA - ARE DIFFERENT ANTITHROMBOTIC DRUGS EQUALLY EFFECTIVE IN PATIENTS UNDERGOING HIP-REPLACEMENT - RETROSPECTIVE ANALYSIS OF 2354 PATIENTS UNDERGOING HIP-REPLACEMENT RECEIVING EITHER RECOMBINANT HIRUDIN, UNFRACTIONATED HEPARIN OR ENOXAPARIN
Authors: ERIKSSON BI EKMAN S BAUR M LINDBRATT S BACH D KALEBO P CLOSE P
Citation: Bi. Eriksson et al., REGIONAL BLOCK ANESTHESIA VERSUS GENERAL-ANESTHESIA - ARE DIFFERENT ANTITHROMBOTIC DRUGS EQUALLY EFFECTIVE IN PATIENTS UNDERGOING HIP-REPLACEMENT - RETROSPECTIVE ANALYSIS OF 2354 PATIENTS UNDERGOING HIP-REPLACEMENT RECEIVING EITHER RECOMBINANT HIRUDIN, UNFRACTIONATED HEPARIN OR ENOXAPARIN, Thrombosis and haemostasis, 1997, pp. 1992-1992
OPTIMAL DOSE-FINDING OF RECOMBINANT HIRUDIN, CGP-39393, DESIRUDIN ((TM)REVASC), IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT
Authors: EKMAN S ERIKSSON BI BAUR M LINDBRATT S KALEBO P BACH D CLOSE P
Citation: S. Ekman et al., OPTIMAL DOSE-FINDING OF RECOMBINANT HIRUDIN, CGP-39393, DESIRUDIN ((TM)REVASC), IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT, Thrombosis and haemostasis, 1997, pp. 2012-2012
RECOMBINANT HIRUDIN, DESIRUDIN ((TM)REVASC), IS MORE EFFECTIVE THAN ENOXAPARIN AS PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT
Authors: ERIKSSON BI BAUR M EKMAN S LINDBRATT S BACH D KALEBO P CLOSE P
Citation: Bi. Eriksson et al., RECOMBINANT HIRUDIN, DESIRUDIN ((TM)REVASC), IS MORE EFFECTIVE THAN ENOXAPARIN AS PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT, Thrombosis and haemostasis, 1997, pp. 2309-2309
EFFECT OF A 15-MINUTE INFUSION OF DDAVP ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF (TM)REVASC DURING A 4-HOUR INTRAVENOUS-INFUSION IN HEALTHY MALE-VOLUNTEERS
Authors: AMIN DM MANT TGK WALKER SM KERRY R LLOYD P LEFEVRE G CLOSE P
Citation: Dm. Amin et al., EFFECT OF A 15-MINUTE INFUSION OF DDAVP ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF (TM)REVASC DURING A 4-HOUR INTRAVENOUS-INFUSION IN HEALTHY MALE-VOLUNTEERS, Thrombosis and haemostasis, 77(1), 1997, pp. 127-132
A COMPARISON OF RECOMBINANT HIRUDIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN TO PREVENT THROMBOEMBOLIC COMPLICATIONS AFTER TOTAL HIP-REPLACEMENT
Authors: ERIKSSON BI WILLEJORGENSEN P KALEBO P MOURET P ROSENCHER N BOSCH P BAUR M EKMAN S BACH D LINDBRATT S CLOSE P
Citation: Bi. Eriksson et al., A COMPARISON OF RECOMBINANT HIRUDIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN TO PREVENT THROMBOEMBOLIC COMPLICATIONS AFTER TOTAL HIP-REPLACEMENT, The New England journal of medicine, 337(19), 1997, pp. 1329-1335
SAFETY AND EFFICACY OF FLUMAZENIL IN THE REVERSAL OF BENZODIAZEPINE-INDUCED CONSCIOUS SEDATION
Authors: SHANNON M ALBERS G BURKHART K LIEBELT E KELLEY M MCCUBBIN MM HOFFMAN J MASSARELLA J PETER J BRITT A DEVENEY A CLOSE P WASSERMAN G MCCUBBIN M SILVERSTEIN E KAUFMAN S WALSON P SCHUTZMAN S CHENEY JP WILEY J PODRAZIK M YOO K
Citation: M. Shannon et al., SAFETY AND EFFICACY OF FLUMAZENIL IN THE REVERSAL OF BENZODIAZEPINE-INDUCED CONSCIOUS SEDATION, The Journal of pediatrics, 131(4), 1997, pp. 582-586
PREVENTION OF THROMBOEMBOLISM WITH USE OF RECOMBINANT HIRUDIN - RESULTS OF A DOUBLE-BLIND, MULTICENTER TRIAL COMPARING THE EFFICACY OF DESIRUDIN (REVASC) WITH THAT OF UNFRACTIONATED HEPARIN IN PATIENTS HAVING A TOTAL HIP-REPLACEMENT
Authors: ERIKSSON BI EKMAN S LINDBRATT S BAUR M BACH D TORHOLM C KALEBO P CLOSE P
Citation: Bi. Eriksson et al., PREVENTION OF THROMBOEMBOLISM WITH USE OF RECOMBINANT HIRUDIN - RESULTS OF A DOUBLE-BLIND, MULTICENTER TRIAL COMPARING THE EFFICACY OF DESIRUDIN (REVASC) WITH THAT OF UNFRACTIONATED HEPARIN IN PATIENTS HAVING A TOTAL HIP-REPLACEMENT, Journal of bone and joint surgery. American volume, 79A(3), 1997, pp. 326-333
EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN
Authors: LEFEVRE G DUVAL M GAURON S BROOKMAN LJ ROLAN PE MORRIS TM PIRAINO AJ MORGAN JM PALMISANO M CLOSE P
Citation: G. Lefevre et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 50-59
A CLINICAL-EVALUATION OF THE INTERNATIONAL LYMPHOMA STUDY-GROUP CLASSIFICATION OF NON-HODGKINS-LYMPHOMA
Authors: CHAN WC ARMITAGE JO GASCOYNE R CONNORS J CLOSE P JACOBS P NORTON A LISTER TA PEDRINIS E CAVALLI F BERGER F COIFFIER B HO F LIANG R SCHAUER A HIDDEMANN W DIEBOLD J MACLENNAN KA MULLERHERMELINK HK NATHWANI BN WEISENBURGER DD HARRIS NL ANDERSON JR ROY P
Citation: Wc. Chan et al., A CLINICAL-EVALUATION OF THE INTERNATIONAL LYMPHOMA STUDY-GROUP CLASSIFICATION OF NON-HODGKINS-LYMPHOMA, Blood, 89(11), 1997, pp. 3909-3918
INVESTIGATION OF CILIARY STRUCTURE AND FUNCTION IN PATIENTS WITH DEFECTS OF LATERALIZATION
Authors: SPLITT MP SAMUEL J CLOSE P CRESSWELL C OSULLIVAN J
Citation: Mp. Splitt et al., INVESTIGATION OF CILIARY STRUCTURE AND FUNCTION IN PATIENTS WITH DEFECTS OF LATERALIZATION, American journal of human genetics, 61(4), 1997, pp. 612-612
ABORTIVE MITOSES AND NUCLEAR-DNA FRAGMENTATION IN CD30-DISEASE( LARGECELLS OF HODGKINS)
Authors: LEONCINI L SPINA D CLOSE P MEGHA T PACENTI L TOSI P PILERI S DEVIVO A KRAFT R LAISSUE JA COTTIER H
Citation: L. Leoncini et al., ABORTIVE MITOSES AND NUCLEAR-DNA FRAGMENTATION IN CD30-DISEASE( LARGECELLS OF HODGKINS), Leukemia & lymphoma, 22(1-2), 1996, pp. 119
RENIN INHIBITORS - CARDIOVASCULAR DRUGS OF THE FUTURE
Authors: WOOD JM CLOSE P
Citation: Jm. Wood et P. Close, RENIN INHIBITORS - CARDIOVASCULAR DRUGS OF THE FUTURE, Cardiovascular drugs and therapy, 10(3), 1996, pp. 309-312
THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT
Authors: HOPPER KD KASALES CJ EGGLI KD TENHAVE TR BELMAN NM POTOK PS VANSLYKE MA OLT GJ CLOSE P LIPTON A HARVEY HA HARTZEL JS
Citation: Kd. Hopper et al., THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT, Journal of computer assisted tomography, 20(6), 1996, pp. 930-937
PERCENTAGE OF INADEQUATE PHLEBOGRAMS AND OBSERVER AGREEMENT IN THROMBOPROPHYLACTIC MULTICENTER TRIALS USING STANDARDIZED METHODOLOGY AND CENTRAL ASSESSMENT
Authors: KALEBO P EKMAN S LINDBRATT S ERIKSSON BI PAULI U ZACHRISSON BE CLOSE P
Citation: P. Kalebo et al., PERCENTAGE OF INADEQUATE PHLEBOGRAMS AND OBSERVER AGREEMENT IN THROMBOPROPHYLACTIC MULTICENTER TRIALS USING STANDARDIZED METHODOLOGY AND CENTRAL ASSESSMENT, Thrombosis and haemostasis, 76(6), 1996, pp. 893-896
PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT - DIRECT THROMBIN INHIBITION WITH RECOMBINANT HIRUDIN, CGP-39393
Authors: ERIKSSON BI EKMAN S KALEBO P ZACHRISSON B BACH D CLOSE P
Citation: Bi. Eriksson et al., PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT - DIRECT THROMBIN INHIBITION WITH RECOMBINANT HIRUDIN, CGP-39393, Lancet, 347(9002), 1996, pp. 635-639
IMMUNOPHENOTYPIC CLASSIFICATION OF CANINE MALIGNANT-LYMPHOMA ON FORMALIN-FIXED PARAFFIN WAX-EMBEDDED TISSUE BY MEANS OF CD3 AND CD79A CELL MARKERS
Authors: MILNER RJ PEARSON J NESBIT JW CLOSE P
Citation: Rj. Milner et al., IMMUNOPHENOTYPIC CLASSIFICATION OF CANINE MALIGNANT-LYMPHOMA ON FORMALIN-FIXED PARAFFIN WAX-EMBEDDED TISSUE BY MEANS OF CD3 AND CD79A CELL MARKERS, Onderstepoort journal of veterinary research, 63(4), 1996, pp. 309-313
AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242
Authors: CHETTY R PULFORD K JONES M MATHIEUMAHUL D CLOSE P HUSSEIN S PALLESEN G RALFKIAER E STEIN H GATTER K MASON D
Citation: R. Chetty et al., AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242, Journal of pathology, 178(3), 1996, pp. 311-315
GROWTH VS DNA STRAND BREAKS IN HODGKINS-DISEASE - IMPAIRED PROLIFERATIVE ABILITY OF HODGKIN AND REED-STERNBERG CELLS
Authors: SPINA D LEONCINI L CLOSE P MEGHA T PACENTI L TOSI P PILERI S SABATTINI E KRAFT R LAISSUE JA COTTIER H
Citation: D. Spina et al., GROWTH VS DNA STRAND BREAKS IN HODGKINS-DISEASE - IMPAIRED PROLIFERATIVE ABILITY OF HODGKIN AND REED-STERNBERG CELLS, International journal of cancer, 66(2), 1996, pp. 179-183
PREDICTORS FOR THE OCCURRENCE OF MAJOR ADVERSE CARDIAC EVENTS IN THE 96 HOURS FOLLOWING PTCA - A MULTIVARIATE-ANALYSIS IN 1141 PATIENTS, TREATED WITH DESIRUDIN OR HEPARIN DURING AND FOLLOWING PTCA FOR UNSTABLEANGINA-PECTORIS (BRAUNWALD CLASSIFICATION)
Authors: HERRMAN JPR BOERSMA E CLOSE P DECKERS JW
Citation: Jpr. Herrman et al., PREDICTORS FOR THE OCCURRENCE OF MAJOR ADVERSE CARDIAC EVENTS IN THE 96 HOURS FOLLOWING PTCA - A MULTIVARIATE-ANALYSIS IN 1141 PATIENTS, TREATED WITH DESIRUDIN OR HEPARIN DURING AND FOLLOWING PTCA FOR UNSTABLEANGINA-PECTORIS (BRAUNWALD CLASSIFICATION), Circulation, 94(8), 1996, pp. 3272-3272
CLINICAL PROGNOSTIC FACTORS ARE STRONGER PREDICTORS OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) THEN PATHOLOGICAL SUBTYPE
Authors: COIFFIER B ANDERSON J ARMITAGE J BERGER F CAVALLI F CHAN W CLOSE P CONNORS J DIEBOLD J GASCOYNE R HARRIS N HIDDEMANN W HO F JACOBS P LIANG R LISTER A MACCLENNAN K MULLERHERMELINK H NATHWANI B NORTON A OTT G PEDRINIS E ROSENBERG S ROY P SCHAUER A WEISENBURGER D
Citation: B. Coiffier et al., CLINICAL PROGNOSTIC FACTORS ARE STRONGER PREDICTORS OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) THEN PATHOLOGICAL SUBTYPE, Blood, 88(10), 1996, pp. 1160-1160
RECOMBINANT BIRUDIN, CGP-39393 15 MG ((TM)REVASC-CIBA), IS THE MOST EFFECTIVE AND SAFE PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT
Authors: EKMAN S ERIKSSON BI LINDBRATT S TOERHOLM C KALEBO P BAUR M BACH D CLOSE P
Citation: S. Ekman et al., RECOMBINANT BIRUDIN, CGP-39393 15 MG ((TM)REVASC-CIBA), IS THE MOST EFFECTIVE AND SAFE PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1093-1093
Risultati: 1-25 | 26-50 | 51-53